B. Scott  Segal  to  Opportunistic Infections
                            
                            
                                This is a "connection" page, showing publications  B. Scott  Segal  has written about  Opportunistic Infections.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.079
         
        
        
     
 
    
        
        - 
            Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fidelus-Gort R, Kasper LH. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol. 2008 Sep; 7(9):796-804.
            
            
                Score: 0.079